|
Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials is a document that was drafted by a multidisciplinary international group including community advocates, research staff, and NGO representatives. The group was convened by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and AVAC. A draft version of the guidelines was then further refined through broad consultation involving a wide range of stakeholders. To download a copy of the full text of this document (in English), click here. UNAIDS is currently translating the document into additional languages which will be available soon.
This is a living document. It will only be useful if it is put into practice, evaluated, edited, updated and made part of the ongoing dialogue around prevention research worldwide.
To that end, AVAC has recently announced a call for proposals for AVAC-supported projects to support Community Consultations on Good Participatory Practice Guidelines (CC-GPP). In addition to funding, AVAC is committed to providing technical support and related materials (including a user-friendly GPP summary document) to interested groups.
----------------------------------------------------------------------------------------------------------------------
Good participatory practice
guidelines for biomedical HIV
prevention trials (English) (additional languages coming soon)
GPP summary document (coming soon)
---------------------------------------------------------------------------------------------------------------------
Community Consultations on Good Participatory Practice Guidelines (CC-GPP)
Request for Proposals (RFP) for Community Consultations on Good Participatory Practice Guidelines (CC-GPP) (click to download the PDF)
English - Español - Français - Português
This website Copyright 2006 AIDS Vaccine Advocacy Coalition
Site Design: Canfield Design Studios, Inc.
|